Psychiatric comorbidity in migraine: a review, Cephalalgia, vol.14, issue.30, pp.519-541, 2005. ,
DOI : 10.1016/0304-3959(90)91085-W
Comportements thérapeutiques des migraineux : à partir de FRAMIG 99, La lettre du neurologue, vol.IV, issue.5, pp.14-16, 2000. ,
Céphalées induites par abus des traitements symptomatiques antalgiques et antimigraineux, Rev. Neurol. (Paris), vol.157, pp.1221-1255, 2001. ,
Etude pharmaco??pid??miologique fran??aise de l???utilisation des triptans en m??decine g??n??rale, Th??rapie, vol.59, issue.5, pp.533-542, 2004. ,
DOI : 10.2515/therapie:2004091
Oral triptans (serotonin 5-HT (1B/1D) agonists) in acute migraine treatment : a meta-analysis of 53 trials, Lancet. nov, vol.17358, issue.9294, pp.1668-75, 2001. ,
Crises migraineuses. Que savons-nous vraiment des triptans ?, Neurologies, vol.5, pp.468-72, 2002. ,
Céphalées quotidiennes chroniques par abus de médicaments antalgiques : diagnostique et prise en charge thérapeutique, Medecine Therapeutique, vol.2009, issue.4, pp.169-80 ,
FRAMIG 2000: Medical and Therapeutic Management of Migraine in France, Cephalalgia, vol.21, issue.4, pp.267-79, 2005. ,
DOI : 10.1016/s0304-3959(02)00348-2
Epidémiologie des céphalées, Rev. Neurol.Tome, vol.156, pp.4-24, 2000. ,
Migraine and Probable Migraine ??? Results of FRAMIG 3, a French Nationwide Survey Carried out According to the 2004 IHS Classification, Cephalalgia, vol.23, issue.12, pp.1146-58, 2005. ,
DOI : 10.1111/j.1600-0447.1983.tb09716.x
Influence of general practitioners' personnel knowledge on migraine in medical attitudes towards their patients suffering from migraine, Rev. Neurol, vol.158, issue.4, pp.439-484, 2002. ,
Diagnostic screen for assessment of the IHS criteria for migraine by general practitionners, Cephalalgia, vol.13, pp.54-59, 1993. ,
Prise en charge des patients migraineux: importance de la première consultation. Douleurs, pp.11-12, 2014. ,
Diagnosis, prevalence estimation and burden measurement in population surveys of headache :presenting the HARDSHIP questionnaire. Headache and Pain, pp.10-1186, 2014. ,
An Epidemiologic Study of Headache Among Adolescents and Young Adults, JAMA: The Journal of the American Medical Association, vol.261, issue.15, p.2211, 1989. ,
DOI : 10.1001/jama.1989.03420150061038
Burden of Migraine in the United States, Archives of Internal Medicine, vol.159, issue.8, pp.813-821, 1999. ,
DOI : 10.1001/archinte.159.8.813
Incremental absenteeism due to headaches in migraine: results from the Mig-Access French national cohort, Cephalalgia, vol.19, issue.5, pp.503-513, 1999. ,
DOI : 10.1046/j.1468-2982.1999.019005503.x
Les relations médecins-migraineux. FRAMIG 2000-III, Douleurs, vol.2, pp.244-246, 2001. ,
Prise en charge de la migraine de l'adulte en médecine générale : Evaluation des pratiques thérapeutiques en aigu et en chronique à l'échelle régionale ,
Conclusion:, The Canadian Journal of Neurological Sciences, vol.29, issue.S2, pp.3-7, 2002. ,
DOI : 10.1097/00001888-200104000-00021
Recognition and management of migraine in primary care: influence of functional impact measured by the headache impact test (HIT) ,
Opioids in Headache, Headache: The Journal of Head and Face Pain, vol.104, issue.Suppl. 1, 2013. ,
DOI : 10.1111/head.12266
Prevalence and description of chronic daily headache in the general population in France, Pain, vol.102, issue.1, pp.143-152, 2003. ,
DOI : 10.1016/s0304-3959(02)00348-2
??tat des lieux de l???utilisation des triptans en France, Douleurs : Evaluation - Diagnostic - Traitement, vol.5, issue.3, pp.5144-148, 2004. ,
DOI : 10.1016/S1624-5687(04)94507-6
Comportements thérapeutiques des migraineux. FRAMIG 2000-II, Douleurs, vol.2, pp.240-246, 2001. ,
Dépression et migraine, p.141, 2012. ,
Analysis of the duration of migraine prophylaxis, Journal of the Neurological Sciences, vol.337, issue.1-2 ,
DOI : 10.1016/j.jns.2013.11.013